Adjuvant Chemoradiotherapy Versus Adjuvant Chemotherapy for Stage III Gastric or Gastroesophageal Junction Cancer After D2/R0 Resection

PURPOSE: To compare the survival benefit in the adjuvant chemoradiotherapy (CRT) group and chemotherapy (CT) group for stage III gastric or gastroesophageal junction (GEJ) cancer after D2/R0 resection. METHODS AND MATERIALS: From January 2011 to May 2018, 819 patients (CRT group: 215 patients, CT gr...

Descripción completa

Detalles Bibliográficos
Autores principales: Shi, Jinming, Kang, Wenzhe, Tang, Yuan, Li, Ning, Jiang, Liming, Yang, Lin, Wang, Shulian, Song, Yongwen, Liu, Yueping, Fang, Hui, Lu, Ningning, Qi, Shunan, Chen, Bo, Li, Yexiong, Tian, Yantao, Jin, Jing
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9314560/
https://www.ncbi.nlm.nih.gov/pubmed/35903692
http://dx.doi.org/10.3389/fonc.2022.916937

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9314560/
https://www.ncbi.nlm.nih.gov/pubmed/35903692
http://dx.doi.org/10.3389/fonc.2022.916937

Ejemplares similares